We are CLBiomed

Cheerland Biomedicine (CLBiomed) aims to build a world-class biotech enterprise, offering a wide array of products and services, ranging from Bio-CDMO, molecular diagnostics, cell therapeutics, and healthcare services. Bio-CDMO is our main focus as we are building the largest biologics development and manufacturing site in the world, serving global biopharma companies.

:: Bio-CDMO @Cheerland »

With a total planned capacity over 1.3ML and maximal bioreactor size at 20KL, and led by a world-class management team, we are building the largest Biologics CDMO platform, providing high-quality, affordable and trusted Bio-CDMO services to global biotech companies.

: Molecular Diagnostics »

Based on the powerful NGS platform and IVD kits developed in-house, we provide molecular diagnostic testing services for cancer and reproductive patients. We also provide consumer genomics products to people who are interested in their “book of life” and genetics-based preventative medicine and health management.

::: Healthcare Services »

We are building an ecosystem of healthcare solutions and services, in our elder-care, rehabilitation projects in several strategically located sites near Beijing, Shanghai and Shenzhen. We provide a full range of services covering molecular diagnostics, disease prevention, chronic disease management, stem cell therapy, and other advanced services.

1340 KL

Bio-CDMO capacity


MDx customers


investment and co-development projects

💖 Any questions regarding Bio-CDMO services, project investment and financing, other products and services, we’d love to hear from you!

CLBiomed Team

Nobel Prize winner, academician of the American Academy of Sciences. One of the most famous scientists of the twentieth century. He co-discovered the DNA double helix structure in 1953 and won the Nobel Prize in Physiology or Medicine in 1962. He is known as “Einstein of Life Sciences” and “Father of DNA” …»

Extensive experiences in capital investment and business operations in China and abroad. He has established several successful companies in various industries at home and abroad, and has successfully led many cross-border and cross-market transformations of the companies he founded.

Renowned financier and entrepreneur, Dr. Ma is currently the chairman of the board of directors of the Shenzhen International Public Welfare Institute, the executive director of the Chinese Finance Society, and the executive director of the Chinese Business Leaders’ Association. Former director and president of China Merchants Bank; Chairman of the National Science and Technology Achievement Transformation Guidance Fund, among other key positions.

25 years of experiences in international biotech & CDMO. Held various executive, technical, and operational leadership positions in biopharmaceutical companies in the U.S., Asia, and Europe. Former Global Head of Technical Operations at BeiGene, and a founding Executive member and Vice President of Samsung Biologics Manufacturing …»


Our team has been very impressed with the top-tier talent at Cheerland CDMO. I believe our antibody development projects are in good hands with Michael, Max and their team. They have the required international experience and expertise to help us quickly push our products into clinical stage and beyond. In addition, their large-scale commercial production capacity will become invaluable to us when we enter a very competitive biomedicine market place.

Every year, I would purchase a physical examination package for my parents. Last year, under the recommendation of a friend, I gave my parents a “tumor susceptibility gene test (advanced package)”. The test report suggested that my father had higher risks for esophageal cancer, prostate cancer, and kidney cancer. My mother has a higher risk of breast cancer and stomach cancer. In response to the test results, my parents have paid more attention to the physical examination in the past two years. At the beginning of this year, my mother found some early cancer tissue in her mammary gland. The doctor said it was relatively early and she was cured by surgical removal of those cells. Thanks to Cheerland’s tumor susceptibility gene test to let my family members understand their own risk of disease, and achieve early detection and early treatment of cancer.

My baby had a fever when he was 3 years old, and the hospital prescribed ibuprofen. After taking it, the fever is down but there was blood in the stool. He was sent to the hospital immediately. The doctor suspected that it may be related to ibuprofen. Cheerland’s “Children’s Drug Metabolic Gene Test” found that the baby’s metabolic capacity for ibuprofen is low, and the normal dose has a large side effect on gastrointestinal toxicity. It is recommended to reduce the dosage of ibuprofen or switch to other analgesic medicine. I always keep this in mind for the baby’s medication.

I have suffered from high blood pressure for many years. I have adjusted my medication plan many times, and it has been increased to a four-drug combination of “amlodipine + valsartan + metoprolol + captopril”. However the effect is still not good. I did a “Hypertension Drug Gene Testing” in Cheerland, which indicated that the use of amlodipine, valsartan, and captopril is not effective. According to the test results, the medication regimen was adjusted to “Nitrendipine + Telmisartan + Metoprolol + Benazepril”. After taking it for a period of time, my blood pressure decreased and was under control.

Seeing that I have gout, the genetic counsellor at Cheerland reminded me that taking diuretic hypertension drugs increases the risk of uric acid and should avoid using these drugs. Thanks for the great service and insights, Cheerland!